• Cholecystokinin octapeptide ammonium workflows

  2026-09-19

  Build reproducible CCK receptor experiments around sulfated peptide handling, concentration control, and orthogonal readouts. This guide connects promotion of atrial natriuretic peptide secretion with neurobehavioral, neuronal, and immune research while keeping model-specific limitations visible.

• Patient-Derived Gastric Cancer Assembloids Explained

  2026-09-18

  A 2025 study in Cancers introduces patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations from the same specimen. The model captures tumor–stroma effects on gene expression and drug sensitivity, creating a more physiologically relevant platform for resistance studies and personalized therapeutic screening.

• Epinephrine Bitartrate: From Receptor Binding to Translation

  2026-09-18

  A mechanistic and strategic guide to using Epinephrine Bitartrate in adrenergic signaling research, with practical advice on binding assays, functional validation, formulation control, and translational interpretation.

• Hexamethonium Bromide: Reading Autonomic Signals

  2026-09-17

  Hexamethonium Bromide enables controlled interrogation of autonomic ganglia in cardiovascular experiments. This article explains how to interpret ganglionic blockade alongside telemetry, baroreflex measurements, and sex-stratified angiotensin II hypertension models.

• IR-1061: From Dye to Reliable NIR-II Data

  2026-09-17

  IR-1061 is a near infrared fluorescent dye for low-background OTN-NIR imaging. This guide explains how its chemistry, formulation state, controls, and measurement design determine whether a bright signal becomes reliable biological data.

• Sex Differences in Angiotensin II Hypertension

  2026-09-16

  The reference study used telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to show that chronic angiotensin II produces a much larger pressor response in conscious male mice than in females. Its findings connect sex-dependent blood pressure regulation with autonomic and baroreflex mechanisms, while also providing a useful framework for neuronal signaling pathway research.

• Tetrahydromagnolol: From CB2 Signaling to Metastasis

  2026-09-16

  Tetrahydromagnolol offers a defined pharmacology for peripheral CB2 receptor studies, with an additional GPR55 antagonism window. This thought-leadership article connects its receptor-level profile to ERM-centered cytoskeletal biology while clearly separating established evidence from translational hypotheses in inflammation, pain, and cancer research.

• DRB at the Transcription–Translation Interface

  2026-09-15

  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is more than a transcriptional elongation inhibitor. Used with appropriate controls, it can help translational researchers separate RNA polymerase II output from m6A-dependent translation, YTHDF1 phase separation, and cell-fate decisions. This article connects DRB mechanism, experimental design, antiviral evidence, and the YTHDF1–IκB–NF-κB–CCND1 axis described in Cell Reports.

• Levofloxacin for Reliable Cell and Resistance Assays

  2026-09-15

  This scenario-driven guide explains how Levofloxacin, SKU B1959, can be incorporated into bacterial susceptibility, osteoblast, calcium deposition, and chondrocyte assays. It emphasizes solvent controls, exposure timing, endpoint-specific interpretation, and practical supplier-selection criteria for reproducible laboratory workflows.

• EdU Imaging in RCC: From S-Phase to Translation

  2026-09-14

  EdU-based measurement can turn a broad antiproliferative observation into a mechanistically interpretable translational endpoint. Using esculin-treated renal cell carcinoma as a case study, this article explains how EdU Imaging Kits (HF488) support rigorous DNA synthesis measurement across microscopy and flow cytometry while clarifying what the assay can—and cannot—prove about mechanism.

• BMN 673 (Talazoparib): Assay Guide

  2026-09-14

  A scenario-driven guide to using BMN 673 (Talazoparib) in viability, proliferation, and DNA-repair studies. It explains how SKU A4153 can support controlled PARP1/2 inhibitor workflows through careful formulation, exposure design, and interpretation of homologous recombination deficiency.

• ABT-199 as a Senescence-Linked Apoptosis Probe

  2026-09-13

  ABT-199, also known as Venetoclax, is a selective BCL-2 inhibitor for dissecting mitochondrial apoptosis and BCL-2 dependence. This article explains how to use it as a mechanistic perturbation tool for interpreting senescence-linked biomarkers such as IL-23R, rather than treating cell loss alone as proof of senolysis.

• Biotin-XX Tyramide Reagent for Surface Proteomics

  2026-09-12

  Biotin-XX Tyramide Reagent combines HRP-driven amplification with membrane-restricted labeling for sensitive cell-surface imaging and proximity proteomics. This guide translates the serotonin-interference findings into practical controls, starting conditions, and troubleshooting strategies for IHC, ISH, and neuronal surface-profiling workflows.

• Saracatinib (AZD0530) Workflows for Src Biology

  2026-09-11

  Saracatinib (AZD0530) combines nanomolar Src/Abl pathway inhibition with practical utility in proliferation, migration, invasion, and signaling assays. This guide translates its cancer biology applications into reproducible workflows while defining a cautious, hypothesis-driven route for studying SFK-dependent synaptic mechanisms.

• Biotin-XX Tyramide Reagent for Spatial Cues

  2026-09-11

  Biotin-XX Tyramide Reagent enables membrane-impermeant signal amplification for resolving cell-surface biology in tissue. This article connects its assay geometry to a Drosophila study of Upd2-directed stem-cell migration, offering a framework for distinguishing localization from mechanism.

7946 records 1/530 page Next 12345 下5页 Last page